Cannabis Weekly Round-Up: US Operator Launches on the CSE

INN rounds some of the biggest news in the cannabis market for the past trading week


This past trading week (March 19-23) the cannabis markets saw a new company enter the public sector on the Canadian Securities Exchange (CSE). A new study projected the benefits of legalizing marijuana for tax purposes in the US, market news and an interview with Namaste Technologies complete this Cannabis Weekly Round-Up.

The Investing News Network (INN) had the chance to catch up with Sean Dollinger, president, and CEO of Namaste Technologies (CSE:N; OTC:NXTTF), to talk about the company’s plans this year and the progress of their recently launched NamasteMD platform.

“Our whole idea is about being a platform, so LPs place their products on our platform; whereas we are the technology behind it,” Dollinger told INN.

Lawmakers for one of the biggest cannabis markets in the US are exploring the possibility of reducing taxes for the drug as a way to combat the existing illegal market. On Thursday (March 15) the Los Angeles Times reported a group of California lawmakers proposed a reduction of state taxes for three years on growing and selling cannabis.

“We need to give legal businesses some temporary tax relief so they do not continue to be undercut by the black market,” Assemblyman Tom Lackey (R-Palmdale) said. According to the Los Angeles Times, if approved the new legislation wants to cut the state excise tax from 15 to 11 percent, in addition to suspending a cultivation tax of USD$148 per pound.

Looking for Cannabis Stocks?

Read our report to find market data, important news and stocks to watch!

A new study projected the benefits a legal framework for cannabis could have on the US economy up to the year 2025. The report, prepared by cannabis research firm New Frontier Data, projected USD$105.6 billion in federal tax revenue benefit for the US by 2025 if marijuana were to be legalized nationwide.

Market News

Aurora Cannabis (TSX:ACB; OTCQB: ACBFF) completed its acquisition for the common shares of CanniMed Therapeutics (TSX:CMED) this week and as such the entire board of directors for CanniMed was replaced. However, it was revealed despite losing his seat on the board, Brent Zettl will continue to be CEO of CanniMed “to ensure a successful transition” for the company and the employees.

GMP Securities analyst Martin Landry issued a note to investors saying he sees Aurora fully valued, even after the CanniMed acquisition.

“By combining with CMED, ACB has evolved into the industry’s largest LP by market cap. with significant platforms to capitalize on both domestic and international growth opportunities,” Landry wrote, according to Cantech Letter. “While we like ACB’s strong balance sheet and growth prospects, we feel these are already reflected in the company’s valuation.

The Green Organic Dutchman Holdings, a private cannabis producer announced this past week it filed an amended and restated preliminary long form prospectus with the securities regulatory authorities as the company prepares for its initial public offering. At the Canaccord Genuity cannabis investor day conference, the company shared with investors it would be preparing for its public launch and revealed it expects to have a completely funded 116,000 kilograms of annual production.

Looking for Cannabis Stocks?

Read our report to find market data, important news and stocks to watch!

This past week CannaRoyalty (CSE:CRZ; OTCQX:CNNRF) and National Access Cannabis (NAC) (TSXV:NAC) revealed an upgrade to their partnership in order to set the foundation for a future in which CannaRoyalty can offer its cannabis products in Canada.

Afzal Hasan, executive vice president for corporate development with CannaRoyalty, told INN said the company doesn’t expect this option to materialize anytime soon, but he outlined the ways in which CannaRoyalty could enter the Canadian retail market eventually.

Another cannabis operator with assets in the US began offering its stock to the Canadian market, by launching publicly on the Canadian Securities Exchange. Cannex Capital Holdings (CSE:CNNX) officially started trading on Wednesday (March 14). Anthony Dutton, CEO of Cannex Holdings said in the statement, the CSE listing will give Cannex an opportunity to “build a strong public shareholder base.”

Beacon Securities analyst Vahan Ajamian told Bloomberg Cannex has the “highest trailing revenue” of any US focused cannabis companies in the public market. He also revealed the company raised $48 million as part of a financing deal.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Editorial Disclosure: The Green Organic Dutchman Holdings is a client of the Investing News Network. This article is not paid-for content.

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Looking for Cannabis Stocks?

Read our report to find market data, important news and stocks to watch!

Get the Latest Cannabis Investing Stock Information

Get the latest information about companies associated with Cannabis Investing delivered directly to your inbox.


By selecting company or companies above, you are giving consent to receive email from those companies. And remember you can unsubscribe at any time.

Looking for Cannabis Stocks?

Read our report to find market data, important news and stocks to watch!
  • I own a large number shares in numerous pot stocks and the information you have concerning some of the ones i own is very informative

    • I have owned TWMJF and ACBFF for up to four months. I do not believe I am in the red. Thereis a rule and that is I would rather be late to the party and be early. I believe I am early,nothing but losing money.

  • Market Correction? It’s hard to figure out what’s really happening. Speculators with their expensive programs tell them exactly where all the new money is going. They put big buck to help drive up the market and just when the new investors are happy to see some gains then puff! It’s all gone… Stolen by rich speculators. Tell me I’m wrong.

  • In my humble opinion iT seems for me the right time now to position in MJ stocks, but do your investigation,


Leave a Reply